Viewing entries tagged
Andy Butenhoff

Disease Control Technologies (DCT) and Clariant donate Royal Sentry® Long Lasting Insecticide Treated Mosquito Nets (LLINs) to charities in Nicaragua on occasion of World Malaria Day 2015

2 Comments

Disease Control Technologies (DCT) and Clariant donate Royal Sentry® Long Lasting Insecticide Treated Mosquito Nets (LLINs) to charities in Nicaragua on occasion of World Malaria Day 2015

·  Following a WHO initiated call to step up the fight against diseases spread by insects, DCT and Clariant have partnered to donate 600 state-of-the-art mosquito nets and curtains to charitable institutions in Nicaragua.

· High quality Royal Sentry® brand Long Lasting Insecticide Treated Nets (LLINs) produced by DCT are equipped with Clariant’s unique slow release technology to prevent malaria transmission and other harmful diseases spread by insects.

Greenville, SC, April 24, 2015 – U.S based Disease Control Technologies (DCT) and its supplier partner Clariant, a world leader in specialty chemicals, donated 600 Long Lasting Insecticide Treated Mosquito Nets (LLINs) and curtains in an effort to combat the spread of Malaria, Dengue, and Chikengunya to four charities in Managua, Nicaragua including Damain Foundation, Conanca Charity, Masaya Hospital, and Asociación Hoy Por Manana. The donations were passed to representatives of the charitable institutions on the occasion of World Malaria Day 2015. With this event the WHO and the global malaria control community highlight the annual death toll of approximately half a million lives that malaria still claims each year.

One of the principal control measures against mosquito transmitted diseases is the usage of World Health Organization (WHO) approved LLINs. The mosquito nets produced by DCT, are one of only a handful of LLIN products fully approved by the WHO, which comply with the strict standards for durability and washability set by the World Health Organization Pesticide Evaluation Scheme (WHOPES). Royal Sentry® brand LLINs are manufactured  from a special additive masterbatch supplied to DCT by Clariant’s Masterbatch Business Unit; the masterbatch contains a pyrethroid insecticide  that is highly effective against insects and safe for for human use. The treated fabric maintains its biological effectiveness for several years, and over 20 home wash cycles.

“Our partnership with DCT has been a brilliant success story in regards to combating the spread of diseases, such as Malaria and Dengue. We are proud to provide the vital and basic components for DCT to create its LLINs and happy to see them in use here in Managua and everywhere people are affected”, comments Francis Baud, Clariant’s BU representative in the field.

Andy Butenhoff, DCT’s Managing Director, states that “DCT is proud to partner with Clariant as a part of a global community striving to eradicate malaria deaths worldwide.  We are hopeful our contributions, both for World Malaria Day 2015 and every day, make a difference to people in countries burdened with malaria and other vector borne diseases.”

One recipient of the donation, Asociación Hoy Por Manana, operates the shelter Hogar San Jose Protector for 70 young girls ages three to eighteen from impoverished families. Ena Flinn, who is representing the board of directors of the charity expressed her gratitude for this “anti-mosquito”effort by Clariant and DCT. “The donation in the spirit of World Malaria Day will help protect the children and their families in their dwellings from contracting such illnesses.”

2 Comments

DCT joins Gates Foundation Innovation to Impact Stakeholder Convening

Comment

DCT joins Gates Foundation Innovation to Impact Stakeholder Convening

Managing Director of Disease Control Technologies, Andy Butenhoff, recently attended the Bill and Melinda Gates Foundation Innovation to Impact (I2I) Stakeholder Convening in Seattle, Washington.  It was an impactful meeting confirming the commitment of all involved to eradicate malaria through vector control.

Gates Foundation has recently committed $500 million to tackle the burden of infections disease in developing countries.  “We must remain committed to the eradication of malaria,” Gates said. “Small steps won’t get the job done. History shows that the only way to stop malaria is to end it forever.”  He emphasized, however, that long-range efforts to achieve eradication must not distract donors and endemic countries from the immediate objective of “saving lives now.”

DCT is committed to saving lives and stamping out malaria.  "We are excited to be a stakeholder in this Gates Foundation initiative," says Butenhoff.  "Over coming months, we will work hand and hand with others to shift from alignment to action in multiple I2I touchpoint areas."

Learn more about the Gates Foundation malaria strategy, Accelerate to zero, at http://www.gatesfoundation.org/What-We-Do/Global-Health/Malaria.

 

Comment